The American Association for Cancer Research (AACR) and the Lung Cancer Initiative at Johnson & Johnson (LCI) recently announced the inaugural recipients of the AACR–Johnson & Johnson Lung Cancer Innovation Science Grants. The grants represent a new funding opportunity to support research that could one day lead to solutions that prevent, intercept, and cure lung cancer.
Grants will be awarded to the following multi-institutional teams:
- James V. DeGregori, PhD, Professor at the University of Colorado Denver, and Tullia Bruno, PhD, Research Assistant Professor at the University of Pittsburgh School of Medicine, will lead a team focused on examining the role of microenvironment-mediated clonal evolution in lung adenocarcinoma.
- Dominique S. Michaud, ScD, Professor at Tufts University School of Medicine; Karl T. Kelsey, MD, Professor of Epidemiology at Brown University; and Elizabeth A. Platz, ScD, Professor of Epidemiology at Johns Hopkins School of Public Health, will lead a team focused on identifying candidate immune markers for early detection of lung cancer.
- Jianjun Zhang, MD, PhD, Assistant Professor, and John V. Heymach, MD, PhD, Professor and Department Chair, both of The University of Texas MD Anderson Cancer Center, and Harvey I. Pass, MD, Professor of Cardiothoracic Surgery at New York University Langone Medical Center, will lead a team focused on understanding immunogenomic and microbiota evolution from premalignancy to lung cancer. ■
